199 related articles for article (PubMed ID: 33597638)
41. Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.
Ruzzin J; Wagman AS; Jensen J
Diabetologia; 2005 Oct; 48(10):2119-30. PubMed ID: 16078016
[TBL] [Abstract][Full Text] [Related]
42. Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal.
Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
[TBL] [Abstract][Full Text] [Related]
43. Modulation of GSK-3β/β-Catenin Signaling Contributes to Learning and Memory Impairment in a Rat Model of Depression.
Hui J; Zhang J; Pu M; Zhou X; Dong L; Mao X; Shi G; Zou J; Wu J; Jiang D; Xi G
Int J Neuropsychopharmacol; 2018 Sep; 21(9):858-870. PubMed ID: 29688389
[TBL] [Abstract][Full Text] [Related]
44. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
46. MSK1-Mediated β-Catenin Phosphorylation Confers Resistance to PI3K/mTOR Inhibitors in Glioblastoma.
Wu S; Wang S; Zheng S; Verhaak R; Koul D; Yung WK
Mol Cancer Ther; 2016 Jul; 15(7):1656-68. PubMed ID: 27196759
[TBL] [Abstract][Full Text] [Related]
47. Activation of AKT1/GSK-3β/β-Catenin-TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model.
Darshit BS; Ramanathan M
Mol Neurobiol; 2016 Dec; 53(10):6716-6729. PubMed ID: 26660108
[TBL] [Abstract][Full Text] [Related]
48. Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression.
Dutta-Simmons J; Zhang Y; Gorgun G; Gatt M; Mani M; Hideshima T; Takada K; Carlson NE; Carrasco DE; Tai YT; Raje N; Letai AG; Anderson KC; Carrasco DR
Blood; 2009 Sep; 114(13):2699-708. PubMed ID: 19652203
[TBL] [Abstract][Full Text] [Related]
49. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
Evangelisti C; Cappellini A; Oliveira M; Fragoso R; Barata JT; Bertaina A; Locatelli F; Simioni C; Neri LM; Chiarini F; Lonetti A; Buontempo F; Orsini E; Pession A; Manzoli L; Martelli AM; Evangelisti C
J Cell Physiol; 2018 Mar; 233(3):1796-1811. PubMed ID: 28777460
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
Soda M; Willert K; Kaushansky K; Geddis AE
Cell Signal; 2008 Dec; 20(12):2317-23. PubMed ID: 18804163
[TBL] [Abstract][Full Text] [Related]
51. Mitogen-activated protein kinases and protein phosphatase 5 mediate glucocorticoid-induced cytotoxicity in pancreatic islets and β-cells.
Fransson L; Rosengren V; Saha TK; Grankvist N; Islam T; Honkanen RE; Sjöholm Å; Ortsäter H
Mol Cell Endocrinol; 2014 Mar; 383(1-2):126-36. PubMed ID: 24361515
[TBL] [Abstract][Full Text] [Related]
52. Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation.
Abdoul-Azize S; Dubus I; Vannier JP
Oncotarget; 2017 Apr; 8(16):27339-27352. PubMed ID: 28423696
[TBL] [Abstract][Full Text] [Related]
53. Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.
Hu K; Gu Y; Lou L; Liu L; Hu Y; Wang B; Luo Y; Shi J; Yu X; Huang H
J Hematol Oncol; 2015 Jan; 8():1. PubMed ID: 25622682
[TBL] [Abstract][Full Text] [Related]
54. Glucocorticoids differentially modulate insulin-mediated protein and glycogen synthetic signaling downstream of protein kinase B in rat myocardium.
Wu Y; Barrett EJ; Long W; Liu Z
Endocrinology; 2004 Mar; 145(3):1161-6. PubMed ID: 14630710
[TBL] [Abstract][Full Text] [Related]
55. Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation.
Chougule RA; Shah K; Moharram SA; Vallon-Christersson J; Kazi JU
NPJ Genom Med; 2019; 4():7. PubMed ID: 30962949
[TBL] [Abstract][Full Text] [Related]
56. Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia.
Serafin V; Capuzzo G; Milani G; Minuzzo SA; Pinazza M; Bortolozzi R; Bresolin S; Porcù E; Frasson C; Indraccolo S; Basso G; Accordi B
Blood; 2017 Dec; 130(25):2750-2761. PubMed ID: 29101238
[TBL] [Abstract][Full Text] [Related]
57. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells.
Failor KL; Desyatnikov Y; Finger LA; Firestone GL
Mol Endocrinol; 2007 Oct; 21(10):2403-15. PubMed ID: 17595317
[TBL] [Abstract][Full Text] [Related]
58. Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
Bornhauser BC; Bonapace L; Lindholm D; Martinez R; Cario G; Schrappe M; Niggli FK; Schäfer BW; Bourquin JP
Blood; 2007 Sep; 110(6):2084-91. PubMed ID: 17537996
[TBL] [Abstract][Full Text] [Related]
59. Activation of Akt/GSK-3beta/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats.
Zhao S; Fu J; Liu X; Wang T; Zhang J; Zhao Y
Neurol Res; 2012 May; 34(4):400-7. PubMed ID: 22643085
[TBL] [Abstract][Full Text] [Related]
60. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
